| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d281e953d189bcfe2507ba7faba72c25 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate |
2020-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca3be64674f10824a3db8f5717c0552d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecab2f174db5c2e3c5bf28ebb1743c54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97a02673afd75bae3df4bbb0b4f3b2f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c635eac4cdaf95da2fc2141f5f8d0249
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e04d707c815eca0c608d80bda6afb9d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c28da10e5a74b4fa48334952be892372
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c24517d0fc55c8abcd66a2a03079a1c |
| publicationDate |
2021-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-112156107-A |
| titleOfInvention |
Application of Lentinus edodes mycelium polysaccharide in the preparation of amylase inhibitory drugs |
| abstract |
The invention belongs to the field of medicines or health products, and discloses the application of Lentinus edodes mycelium polysaccharide used alone or in combination with other medicines in medicines for inhibiting amylase activity. The Lentinus edodes mycelium polysaccharide can reduce the postprandial and fasting blood glucose levels by inhibiting the activity of amylase, thereby achieving the effect of preventing diabetes. The Lentinus edodes mycelium polysaccharide disclosed in the invention is derived from the Lentinus edodes mycelium, can better inhibit the activity of amylase, and provides theoretical basis and experimental basis for the development of health care products and medicines for preventing diabetes. Therefore, the mushroom mycelium polysaccharide disclosed in the present invention provides a new idea for the development of hypoglycemic health care products. |
| priorityDate |
2020-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |